In Maine, the "Church of Safe Injection" illegally distributes clean syringes. Branding as a "religion" may offer some legal protection.

Drug makers contributed more than $72 million to hundreds of U.K. patient advocacy groups that lobby and facilitate research into new treatments.

Known as Zolgensma, the gene therapy treats children under two years of age with spinal muscular atrophy, an inherited neuromuscular disease.

It’s the first study to compare mortality rates between two groups of professional athletes; previous studies compared them to the general population.

The decline in deals underscores the fact that brand-name and generic drug makers can settle patent litigation without resorting to anti-competitive terms.

Alexandra Glorioso, a health care reporter for Politico, talks about what it’s like to report on this world while undergoing treatment for breast cancer.

Snakebites kill as many as 100,000 people a year, a number that is likely to grow as snakes migrate in response to climate change.

Just months after they were sworn in, two lawmakers who defied party orthodoxy by campaigning on Medicare negotiation already appear to have abandoned it.

“The society’s precarious financial position had been compounded and complicated by spurious lawsuits and subpoenas," the APS board wrote to its members.

The controversy is centered on work by Ram Sasisekharan, a professor of bioengineering whose algorithm-based methods were used to discover new medicines.

In this episode, Politico reporter Alexandra Glorioso shares what it’s like to cover health care while undergoing treatment for breast cancer.

Many expected the new draft proposal to focus more on surprise medical bills than on drug pricing, but its policies toward PBMs are surprisingly ambitious.

The change comes as Glaxo attempts to compete in the burgeoning oncology market and also underscores an attempt to revamp the company more broadly.

The dispute has come to symbolize the growing friction between drug makers and governments over the rising cost of medicines.

The analysis by the Institute for Clinical and Economic Review threatens to renew questions about a drug that caused debate over FDA approval standards.

Viewing health care as a menu of services from which patients can choose opens the door to their making racist comments to doctors.

Manufacturing bacteria for drugs is really hard — the biggest and clearest hurdle for the otherwise exploding microbiome industry.

Legal experts suggest that if Catalyst goes to court, its lawyers may argue the company was not treated fairly under a federal law.

Because of herd immunity, some communicable diseases are much less likely to find and infect the vulnerable if most of the population is immune to them.

Noted psychiatrist and former Verily leader Dr. Tom Insel is going to be the “mental health czar” for the state of California, Gov. Gavin Newsom announced.

The lawmakers say World Health guidelines contain “dangerously misleading” and “outright false claims” about opioids, orchestrated by Purdue Pharma.

A Northwestern Medicine team spent months building “middleware” — the software equivalent of untangling endless brambles of Christmas lights.

Under the Affordable Care Act, health insurance plans must cover recommended vaccines with no out-of-pocket costs. Ousting it threatens public health.